Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography. 1998

J Tiihonen, and H Vilkman, and P Räsänen, and O P Ryynänen, and H Hakko, and J Bergman, and T Hämäläinen, and A Laakso, and M Haaparanta-Solin, and O Solin, and M Kuoppamäki, and E Syvälahti, and J Hietala
Department of Forensic Psychiatry, University of Kuopio, Finland.

Recent in vivo studies have shown low dopamine D2 receptor and dopamine transporter densities among late onset (type 1) alcoholics. We have now studied 6-[18F]-FDOPA (FDOPA) uptake in 10 type 1 alcoholics and eight matched controls to test the hypothesis that striatal presynaptic dopamine function is lower among alcoholics. Markedly low FDOPA uptake (Ki) was observed in the left caudate of two alcoholic patients, but the mean striatal uptake values of the patient group were higher than those of the control group. The greatest difference was observed in the mean FDOPA intake in the left putamen, which was 28% higher in the patient group (t = 3.00, P = 0.008, d.f. = 16, independent samples t-test), and in the right caudate (difference 36%, t = 2.87, P = 0.01). The elevated FDOPA uptake in putamen and caudate correlated with poor Wisconsin Card Sorting Test (WCST) performance (error %) among alcoholics (correlation coefficients from 0.49 to 0.56), which suggests that the magnitude of presynaptic dopamine function alteration correlates with the degree of disability to modify one's behavior. The results do not give support to the hypothesis of generally decreased striatal dopamine turnover in type 1 alcoholism, but on the contrary indicate an increased presynaptic dopamine function. This may represent a compensatory mechanism to low postsynaptic DA function. The low presynaptic DA function observed in the left caudate of two patients suggests that type 1 alcoholism may be a heterogeneous disorder.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008959 Models, Neurological Theoretical representations that simulate the behavior or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Neurologic Models,Model, Neurological,Neurologic Model,Neurological Model,Neurological Models,Model, Neurologic,Models, Neurologic
D008960 Models, Psychological Theoretical representations that simulate psychological processes and/or social processes. These include the use of mathematical equations, computers, and other electronic equipment. Model, Mental,Model, Psychological,Models, Mental,Models, Psychologic,Psychological Models,Mental Model,Mental Models,Model, Psychologic,Psychologic Model,Psychologic Models,Psychological Model
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D011699 Putamen The largest and most lateral of the BASAL GANGLIA lying between the lateral medullary lamina of the GLOBUS PALLIDUS and the EXTERNAL CAPSULE. It is part of the neostriatum and forms part of the LENTIFORM NUCLEUS along with the GLOBUS PALLIDUS. Nucleus Putamen,Nucleus Putamens,Putamen, Nucleus,Putamens,Putamens, Nucleus
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier

Related Publications

J Tiihonen, and H Vilkman, and P Räsänen, and O P Ryynänen, and H Hakko, and J Bergman, and T Hämäläinen, and A Laakso, and M Haaparanta-Solin, and O Solin, and M Kuoppamäki, and E Syvälahti, and J Hietala
August 1996, Psychopharmacology,
J Tiihonen, and H Vilkman, and P Räsänen, and O P Ryynänen, and H Hakko, and J Bergman, and T Hämäläinen, and A Laakso, and M Haaparanta-Solin, and O Solin, and M Kuoppamäki, and E Syvälahti, and J Hietala
January 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience,
J Tiihonen, and H Vilkman, and P Räsänen, and O P Ryynänen, and H Hakko, and J Bergman, and T Hämäläinen, and A Laakso, and M Haaparanta-Solin, and O Solin, and M Kuoppamäki, and E Syvälahti, and J Hietala
April 1997, Neurology,
J Tiihonen, and H Vilkman, and P Räsänen, and O P Ryynänen, and H Hakko, and J Bergman, and T Hämäläinen, and A Laakso, and M Haaparanta-Solin, and O Solin, and M Kuoppamäki, and E Syvälahti, and J Hietala
January 1993, European journal of clinical pharmacology,
J Tiihonen, and H Vilkman, and P Räsänen, and O P Ryynänen, and H Hakko, and J Bergman, and T Hämäläinen, and A Laakso, and M Haaparanta-Solin, and O Solin, and M Kuoppamäki, and E Syvälahti, and J Hietala
January 2009, Synapse (New York, N.Y.),
J Tiihonen, and H Vilkman, and P Räsänen, and O P Ryynänen, and H Hakko, and J Bergman, and T Hämäläinen, and A Laakso, and M Haaparanta-Solin, and O Solin, and M Kuoppamäki, and E Syvälahti, and J Hietala
December 1993, Proceedings of the National Academy of Sciences of the United States of America,
J Tiihonen, and H Vilkman, and P Räsänen, and O P Ryynänen, and H Hakko, and J Bergman, and T Hämäläinen, and A Laakso, and M Haaparanta-Solin, and O Solin, and M Kuoppamäki, and E Syvälahti, and J Hietala
January 2005, Brain research,
J Tiihonen, and H Vilkman, and P Räsänen, and O P Ryynänen, and H Hakko, and J Bergman, and T Hämäläinen, and A Laakso, and M Haaparanta-Solin, and O Solin, and M Kuoppamäki, and E Syvälahti, and J Hietala
November 1983, Brain research,
J Tiihonen, and H Vilkman, and P Räsänen, and O P Ryynänen, and H Hakko, and J Bergman, and T Hämäläinen, and A Laakso, and M Haaparanta-Solin, and O Solin, and M Kuoppamäki, and E Syvälahti, and J Hietala
August 1986, Journal of neurology, neurosurgery, and psychiatry,
J Tiihonen, and H Vilkman, and P Räsänen, and O P Ryynänen, and H Hakko, and J Bergman, and T Hämäläinen, and A Laakso, and M Haaparanta-Solin, and O Solin, and M Kuoppamäki, and E Syvälahti, and J Hietala
February 2009, Alcoholism, clinical and experimental research,
Copied contents to your clipboard!